Health News Archive - May 29, 2009
A dog born with a deadly disease that prevents the body from using stored sugar has survived 20 months and is still healthy after receiving gene therapy at the University of Florida â€” putting scientists a step closer to finding a cure for the disorder in children.
Oxidative stress has been linked to aging, cancer and other diseases in humans. Paradoxically, researchers have suggested that small exposure to oxidative conditions may actually offer protection from acute doses.
As the best drugs become increasingly resistant to superbugs, McMaster University researchers have discovered a completely different way of looking for a new antibiotic.
TUSTIN, Calif., May 29 /PRNewswire/ -- Exiqon Diagnostics, announced today a strategic commercial partnership with MedTrust Online, an innovative, comprehensive internet based solution provider for oncologists that offers clinically useful knowledge on the latest topics in cancer treatment.
Current tests to identify specific strains of infectious prions, which cause a range of transmissible diseases (such as mad cow) in animals and humans, can take anywhere from six months to a year to yield results â€“ a time-lag that may put human populations at risk.
Viewing a video showing a patient with advanced dementia interacting with family and caregivers may help elderly patients plan for end-of-life care, according to a study led by Massachusetts General Hospital (MGH) researchers.
DALLAS, May 29 /PRNewswire/ -- BeaconEquity.com announces availability of alerts on pharmaceutical companies poised to wrap up the week with heavy trading. The alerts include recent news, trading activity and technical analysis.
The World Health Organization announced Friday that cigarette packages should incorporate pictures of the results of smoking tobacco, in addition to the written warnings.
- Oxycodone Successfully Delivered into the Bloodstream - Data Demonstrates Sustained Release and Increased Blood Levels of Oxycodone MELBOURNE, Australia, May 29 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH; OTCQX: PPGNY) today announced the successful completion of preclinical studies related to its patented TPM/oxycodone transdermal patch system.
Portions of the brain that activate when people view pictures of objects compared to scrambled images can also be activated by touch alone.